SI1951272T1 - Uporaba lactobacillus za zdravljenje virusnih infekcij - Google Patents

Uporaba lactobacillus za zdravljenje virusnih infekcij

Info

Publication number
SI1951272T1
SI1951272T1 SI200632096A SI200632096A SI1951272T1 SI 1951272 T1 SI1951272 T1 SI 1951272T1 SI 200632096 A SI200632096 A SI 200632096A SI 200632096 A SI200632096 A SI 200632096A SI 1951272 T1 SI1951272 T1 SI 1951272T1
Authority
SI
Slovenia
Prior art keywords
lactobacillus
treatment
virus infections
infections
virus
Prior art date
Application number
SI200632096A
Other languages
English (en)
Inventor
Jan Alenfall
Anna Berggren
Carola Rask
Agnes Wold
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of SI1951272T1 publication Critical patent/SI1951272T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/40—Products characterised by the type, form or use
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/02—Products made from whole meal; Products containing bran or rough-ground grain
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/06—Products with modified nutritive value, e.g. with modified starch content
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/267—Microbial proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D8/00—Methods for preparing or baking dough
    • A21D8/02—Methods for preparing dough; Treating dough prior to baking
    • A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/045—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with a leaven or a composition containing acidifying bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/857—Lactobacillus plantarum
SI200632096A 2005-10-06 2006-10-06 Uporaba lactobacillus za zdravljenje virusnih infekcij SI1951272T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0502209 2005-10-06
SE0502250 2005-10-07
PCT/SE2006/001138 WO2007040445A1 (en) 2005-10-06 2006-10-06 Use of lactobacillus for treatment of virus infections
EP06799738.7A EP1951272B1 (en) 2005-10-06 2006-10-06 Use of lactobacillus for treatment of virus infections

Publications (1)

Publication Number Publication Date
SI1951272T1 true SI1951272T1 (sl) 2016-10-28

Family

ID=37906406

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200632096A SI1951272T1 (sl) 2005-10-06 2006-10-06 Uporaba lactobacillus za zdravljenje virusnih infekcij

Country Status (18)

Country Link
US (3) US8420376B2 (sl)
EP (2) EP1951272B1 (sl)
JP (2) JP5792919B2 (sl)
KR (2) KR101300077B1 (sl)
AU (2) AU2006297896B2 (sl)
BR (2) BRPI0616962B8 (sl)
CA (2) CA2625074C (sl)
CY (1) CY1118006T1 (sl)
DK (2) DK1951272T3 (sl)
ES (2) ES2460891T3 (sl)
HU (1) HUE030542T2 (sl)
IN (2) IN2008DE02592A (sl)
LT (1) LT1951272T (sl)
PL (2) PL1951272T3 (sl)
PT (1) PT1951272T (sl)
RU (2) RU2440123C2 (sl)
SI (1) SI1951272T1 (sl)
WO (3) WO2007040446A1 (sl)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5019961B2 (ja) * 2006-06-26 2012-09-05 株式会社ヤクルト本社 インターロイキン１０産生促進剤
AU2007302715B2 (en) 2006-10-02 2013-01-31 International N&H Denmark Aps Probiotics for use in reducing the incidence and duration of illness
PL210465B1 (pl) 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
JP2009057346A (ja) * 2007-09-03 2009-03-19 Kirin Holdings Co Ltd 免疫バランス調節用組成物
FR2922450B1 (fr) * 2007-10-19 2014-06-13 Lallemand Sas Utilisation de bacteries lactique pour la prevention et/ou le traitement de pathologies cutanees
US20090124573A1 (en) 2007-11-09 2009-05-14 Sarkis Mazmanian Immunomodulating compounds and related compositions and methods
EP2153837A1 (en) * 2008-08-14 2010-02-17 Compagnie Gervais Danone Compositions comprising Lactobacillus casei for improving resistance to common infectious diseases
SE533778C2 (sv) * 2009-05-14 2011-01-11 Probi Ab Probiotisk fruktdryck
US20100311686A1 (en) * 2009-06-03 2010-12-09 Kasper Lloyd H Nutraceutical composition and methods for preventing or treating multiple sclerosis
WO2011059332A2 (en) 2009-11-16 2011-05-19 Stichting Top Institute Food And Nutrition Improved immunomodulation by probiotics
KR20110082480A (ko) * 2010-01-11 2011-07-19 포항공과대학교 산학협력단 포유동물 체내에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도
CA2787544C (en) * 2010-01-28 2019-07-09 Ab-Biotics S.A. Probiotic composition for use in the treatment of bowel inflammation
EP2555753B1 (en) 2010-04-07 2018-08-01 California Institute of Technology Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
EP2571982A4 (en) 2010-05-20 2014-01-01 California Inst Of Techn ANTIGEN-SPECIFIC TREGS AND CORRESPONDING COMPOSITIONS, METHODS AND SYSTEMS
CN103458904B (zh) * 2010-12-16 2016-09-28 株式会社明治 格氏乳杆菌的菌体级分在制造用于减轻迟发型***反应的组合物中的用途
SG191040A1 (en) 2010-12-23 2013-08-30 Pfizer Glucagon receptor modulators
WO2012093755A1 (ko) * 2011-01-04 2012-07-12 포항공과대학교 산학협력단 발효식품에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도
BR112013020035A2 (pt) 2011-02-08 2016-07-19 Pfizer moduladores do receptor do glucagon
JP5261617B2 (ja) * 2011-03-31 2013-08-14 森永乳業株式会社 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
KR101378608B1 (ko) * 2011-04-13 2014-03-27 씨제이제일제당 (주) 바이러스 감염 억제 활성을 갖는 신규 분리한 락토바실러스 퍼멘텀 균주
KR101279852B1 (ko) * 2011-06-29 2013-07-09 주식회사 쎌바이오텍 골다공증 예방 또는 치료용 조성물
US9539281B2 (en) 2011-07-12 2017-01-10 The Brigham And Women's Hospital, Inc. Lipid-containing PSA compositions, methods of isolation and methods of use thereof
CA2841237C (en) 2011-07-22 2016-05-10 Pfizer Inc. Quinolinyl glucagon receptor modulators
WO2013099883A1 (ja) 2011-12-28 2013-07-04 株式会社山田養蜂場本社 IgA産生促進作用を有する新規乳酸菌及びその用途
JP6028962B2 (ja) * 2012-02-16 2016-11-24 国立大学法人金沢大学 ウイルス感染予防乳酸菌組成物及びウイルス感染予防乳酸発酵食品
JP5995593B2 (ja) * 2012-08-02 2016-09-21 丸善製薬株式会社 抗炎症剤
WO2014038929A1 (en) 2012-09-07 2014-03-13 N.V. Nutricia Probiotics for producing antiviral factors
FR2997960B1 (fr) * 2012-11-09 2016-08-05 Inst Nat De La Rech Agronomique (Inra) Nouvelle souche bacterienne de lactobacillus plantarum et utilisation de cette souche
BR112015010978A2 (pt) 2012-11-16 2017-07-11 Calpis Co Ltd agente para alívio de distúrbio intestinal induzido por estresse contendo cepa de lactobacillus gasseri específica ou produto tratado da mesma
PL2981274T3 (pl) * 2013-04-03 2020-12-28 Probi Ab Szczepy probiotyczne do stosowania w leczeniu lub zapobieganiu osteoporozie
JP2016521284A (ja) 2013-05-10 2016-07-21 カリフォルニア インスティチュート オブ テクノロジー 大腸ガンのプロバイオティクスによる防止および処置
CA2897722C (en) * 2013-07-12 2016-07-12 Morinaga Milk Industry Co., Ltd. Lactobacillus paracasei for immunostimulation, and medicine, food, beverage and feed containing the lactobacillus
TWI505831B (zh) * 2013-11-15 2015-11-01 Genmont Biotech Inc 用於治療微小核糖核酸病毒感染的益生菌組合物及其用途
TWI505832B (zh) 2014-02-21 2015-11-01 Genmont Biotech Inc 乳酸菌、其組合物與彼等於治療自體免疫疾病暨其倂發症之用途
KR101644595B1 (ko) * 2014-07-11 2016-08-03 한국식품연구원 락토바실러스 파라카제이(Lactobacillus paracasei)를 유효성분으로 포함하는 Ｔｈ1-매개 면역 질환 또는 Ｔｈ2-매개 면역 질환의 예방, 개선 또는 치료용 조성물
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
EP3337321A4 (en) 2015-08-19 2019-07-17 President and Fellows of Harvard College LIPIDED PSA COMPOSITIONS AND METHOD
KR101749222B1 (ko) * 2016-01-04 2017-06-21 주식회사 카브 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물
EP3196318A1 (en) 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
GB201600975D0 (en) 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof
WO2017125447A1 (en) * 2016-01-19 2017-07-27 Symrise Ag Probiotics for use as anti-inflammatory agents in the oral cavity
EP3222282A1 (en) * 2016-03-21 2017-09-27 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of psoriasis
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
CN106562462A (zh) * 2016-11-04 2017-04-19 覃贤强 一种富硒保健汤圆及其制备方法
KR102500496B1 (ko) * 2017-01-12 2023-02-16 프로비 에이비 프로바이오틱 조성물 및 이의 사용
EP3351259A1 (en) 2017-01-18 2018-07-25 Symrise AG Probiotics for aggregation with disease-associated species in the oral cavity
MX2019009079A (es) 2017-01-31 2019-09-26 Univ Industry Cooperation Group Kyung Hee Univ Nuevas bacterias acido lacticas y usos de las mismas.
EP3578637A4 (en) * 2017-01-31 2020-12-16 University - Industry Cooperation Group of Kyung Hee University NEW LACTIC BACTERIA AND THEIR USE
GB201709763D0 (en) * 2017-06-19 2017-08-02 Probi Ab Biological materials and methods
JP6942030B2 (ja) * 2017-11-02 2021-09-29 株式会社ヤクルト本社 抗アレルギー剤感受性判定マーカー
KR102188020B1 (ko) * 2018-05-09 2020-12-07 주식회사 고바이오랩 락토바실러스 파라카제이 균주 및 그 용도
CA3101175A1 (en) 2018-05-23 2019-11-28 Ko Biolabs, Inc. Lactobacillus gasseri kbl697 strain and use thereof
WO2019242839A1 (en) * 2018-06-18 2019-12-26 Probi Ab Lactobacillus plantarum compositions and uses thereof
CN112584848A (zh) * 2018-06-18 2021-03-30 普罗比公司 益生菌组合物及其用途
WO2020001747A1 (en) * 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
AU2019365399A1 (en) 2018-10-24 2021-04-22 Novozymes A/S Probiotic supplement for metabolic health comprising lactobacillus
US11058634B2 (en) 2018-11-19 2021-07-13 Steven J. Edwards Adherent oral pharmabiotic delivery strip
WO2020118576A1 (zh) * 2018-12-12 2020-06-18 生合生物科技股份有限公司 胚芽乳酸杆菌twk10在制备抗运动后发炎或降体脂组合物的用途
GB201905386D0 (en) * 2019-04-16 2019-05-29 Probi Ab Probiotic compositions and uses thereof
IT201900013740A1 (it) * 2019-08-01 2021-02-01 Nutrilinea S R L Composition comprising S-adenosyl-L-methionine and a probiotic for use to treat depression
JP7195714B2 (ja) * 2020-10-19 2022-12-26 曽根ファーム株式会社 炎症性腸疾患用組成物
CN111035663B (zh) * 2020-01-17 2023-07-14 广州医科大学附属口腔医院（广州医科大学羊城医院） 酸鱼乳杆菌10851在制备治疗多发性硬化的药物中的应用
IT202000007675A1 (it) * 2020-04-09 2021-10-09 Sofar Spa Ivermectina e sue composizioni per uso nel trattamento di infezioni da coronavirus principalmente a carico dell’apparato respiratorio
US20230263845A1 (en) 2020-05-29 2023-08-24 Tohoku University Antiviral Agent
AU2021286002A1 (en) * 2020-06-06 2023-01-19 Quorum Innovations, Llc Materials and methods for inhibiting a viral infection, including a coronavirus infection
KR20220091427A (ko) 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 락토바실러스 사케아이 유래 세포밖 소포체를 유효성분으로 포함하는 자가면역질환의 개선, 예방 또는 치료용 조성물
CN114317343A (zh) * 2021-12-28 2022-04-12 杭州普元生物技术有限公司 一种植物乳杆菌及其在预防和/或治疗中枢神经***疾病中的应用
CN114085798B (zh) * 2021-12-28 2023-10-31 杭州普元生物技术有限公司 一种植物乳杆菌及其在预防和/或治疗疾病中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983163A (en) * 1981-10-09 1991-01-08 Science Research Center, Inc. Method, compositions and articles for prevention and treatment of herpes simplex virus infections
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP4064481B2 (ja) 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 免疫賦活剤
JP4163276B2 (ja) * 1998-02-05 2008-10-08 独立行政法人理化学研究所 機能性組成物
EP1117414A1 (en) * 1998-10-01 2001-07-25 Probi Ab Reduction of oxidative stress factors
EP1020123A1 (en) * 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
MXPA01009017A (es) * 1999-03-11 2002-04-24 Nestle Sa Cepas de lactobacillus capaces de evitar diarrea causada por bacterias patogenicas y rotavirus.
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
EP1084709A1 (en) * 1999-09-17 2001-03-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Oral recombinant lactobacilli vaccines
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
SE0003045D0 (sv) * 2000-08-29 2000-08-29 Probi Ab New method
SE0003100D0 (sv) * 2000-09-01 2000-09-01 Probi Ab New strains
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
AU2002341384A1 (en) 2001-09-05 2003-03-24 Actial Farmaceutica, Lda. Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
US20040022775A1 (en) 2002-04-15 2004-02-05 Gregor Reid Methods of treating viral infections in mammals
US20040002275A1 (en) * 2002-06-28 2004-01-01 Niranjan Thakore Fabric reinforced rubber product
JP4034632B2 (ja) * 2002-10-01 2008-01-16 ハウスウェルネスフーズ株式会社 乳酸菌含有炊飯用組成物
SE526711C2 (sv) * 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
CA2526158A1 (en) * 2003-05-22 2004-12-02 Synbiotics Ab A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survivalproperty, intestinal binding property, an infection protection property and a fiber fermenting property
WO2005007834A1 (en) * 2003-07-23 2005-01-27 Probionic Corp. Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
US7842495B2 (en) * 2003-08-21 2010-11-30 Otsuka Pharmaceutical Co., Ltd. Lactic acid bacteria capable of stimulating mucosal immunity
SE0400355D0 (sv) * 2004-02-17 2004-02-17 Synbiotics Ab New synbiotec use
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
CN101128182B (zh) * 2004-11-25 2011-11-16 荷兰联合利华有限公司 重链和结构域抗体

Also Published As

Publication number Publication date
CA2625074C (en) 2016-05-10
RU2008118007A (ru) 2009-11-20
ES2460891T3 (es) 2014-05-14
JP5792919B2 (ja) 2015-10-14
CA2625074A1 (en) 2007-04-12
IN2008DE02606A (sl) 2008-07-04
DK1951272T3 (en) 2016-09-19
HUE030542T2 (en) 2017-05-29
PL1951272T3 (pl) 2016-12-30
US8691214B2 (en) 2014-04-08
PL1951273T3 (pl) 2014-07-31
KR101300086B1 (ko) 2013-08-30
US8936783B2 (en) 2015-01-20
EP1951272A4 (en) 2010-01-27
US8420376B2 (en) 2013-04-16
AU2006297896B2 (en) 2011-12-08
EP1951273A1 (en) 2008-08-06
CA2624660A1 (en) 2007-04-12
IN2008DE02592A (sl) 2008-07-04
JP2009511470A (ja) 2009-03-19
BRPI0616962B1 (pt) 2019-09-17
AU2006297895B2 (en) 2011-09-01
AU2006297895A1 (en) 2007-04-12
PT1951272T (pt) 2016-09-20
KR101300077B1 (ko) 2013-08-30
JP5419455B2 (ja) 2014-02-19
RU2417092C2 (ru) 2011-04-27
BRPI0616960B1 (pt) 2019-10-08
JP2009511471A (ja) 2009-03-19
RU2440123C2 (ru) 2012-01-20
WO2007040445A1 (en) 2007-04-12
KR20080080981A (ko) 2008-09-05
KR20080081146A (ko) 2008-09-08
EP1951272B1 (en) 2016-06-15
US20100034877A1 (en) 2010-02-11
BRPI0616960B8 (pt) 2021-05-25
BRPI0616960A2 (pt) 2011-07-05
BRPI0616962A2 (pt) 2011-07-05
US20090208469A1 (en) 2009-08-20
EP1951273A4 (en) 2010-02-17
EP1951272A1 (en) 2008-08-06
CA2624660C (en) 2016-07-12
WO2007040446A1 (en) 2007-04-12
EP1951273B1 (en) 2014-02-12
RU2008118008A (ru) 2009-11-20
AU2006297896A1 (en) 2007-04-12
DK1951273T3 (da) 2014-05-05
LT1951272T (lt) 2016-10-10
CY1118006T1 (el) 2017-05-17
US20130017261A1 (en) 2013-01-17
BRPI0616962B8 (pt) 2021-05-25
WO2007040444A1 (en) 2007-04-12
ES2590916T3 (es) 2016-11-24

Similar Documents

Publication Publication Date Title
SI1951272T1 (sl) Uporaba lactobacillus za zdravljenje virusnih infekcij
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
IL257622B (en) Methods and preparations for the treatment of persistent infections
IL250858A0 (en) Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
HK1221956A1 (zh) 用於治療感染的鹵代類苯酞化硼
HK1134679A1 (zh) 用於治療感染的組合物和方法
ZA200709727B (en) Compounds and methods for the treatment of prevention of flavivirus infections
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
IL179873A0 (en) Methods of treatment of endobronchial infections
EP1865967A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND OTHER DISEASES
HK1156038A1 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
IL195272A0 (en) Methods and compositions for the treatment of viral infections
IL182785A0 (en) Particles for treatment of pulmonary infection
GB0513096D0 (en) Treatment of microbial infections
GB2411354B (en) Use of Scutellaria for the treatment of viral infections
PL2132215T3 (pl) Związki do zapobiegania lub leczenia zakażeń wirusowych i sposoby ich stosowania
ZA200904068B (en) Anti-tsg101 antibodies and their uses for treatment of viral infections
IL180459A0 (en) Treatment of bacterial infections
PL2117563T3 (pl) Zastosowanie antybiotyków amidynoantracyklinowych do leczenia infekcji wirusowych
ZA200800201B (en) Composition and the use thereof for the treatment of viral infections
GB0518003D0 (en) Treatment of hepatatis c
GB0622841D0 (en) Treatment of staphylococcal infections